Singapore markets closed
Straits Times Index
3,270.98 -11.90 (-0.36%) Nikkei
27,990.84 -258.40 (-0.91%) Hang Seng
20,228.71 +182.94 (+0.91%) FTSE 100
7,482.37 +42.63 (+0.57%) BTC-USD
23,849.58 +535.15 (+2.30%) CMC Crypto 200
557.27 +14.39 (+2.65%)
Viatris Inc. (VTRS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 9.73 |
| Open | 10.18 |
| Bid | 10.08 x 36100 |
| Ask | 10.15 x 21500 |
| Day's range | 10.02 - 10.62 |
| 52-week range | 9.45 - 15.60 |
| Volume | |
| Avg. volume | 11,714,740 |
| Market cap | 12.232B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 72.07 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.48 (4.93%) |
| Ex-dividend date | 23 May 2022 |
| 1y target est | N/A |
- Zacks
Viatris' (VTRS) Q2 Earnings Beat, Revenues Miss Estimates
Viatris (VTRS) beats on Q2 earnings but misses sales estimates. The company is on track to close its biosimilars deal with Biocon Biologics in the second half.
- Zacks
Viatris (VTRS) Surpasses Q2 Earnings Estimates
Viatris (VTRS) delivered earnings and revenue surprises of 8.64% and 0.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Viatris Q2 Preview: Can Shares Snap Their Downtrend?
Even over the last month, when the S&P 500 has rallied for an 8% gain, Viatris shares have continued their downwards trajectory, declining 5.5% in value.
© 2022 Yahoo. All rights reserved.
